|
[1]
|
Petras, M., Tatarkova, Z., Kovalska, M., et al. (2014) Hyperhomocysteinemia as a Risk Factor for the Neuronal System Disorders. JPP, 65, 15-23.
|
|
[2]
|
Ashjazadeh, N., Fathi, M. and Shariat, A. (2013) Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes. Iranian Journal of Medical Sciences, 38, 233-239.
|
|
[3]
|
Goldstein, L.B., Bushnell, C.D., Adams, R.J., et al. (2011) Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 42, 517-584. http://dx.doi.org/10.1161/STR.0b013e3181fcb238 [Google Scholar] [CrossRef]
|
|
[4]
|
陈伟伟, 高润霖, 刘力生, 等. 中国心血管病报告2013概要[J]. 中国循环杂志, 2014, 29(7): 487-491.
|
|
[5]
|
Collin, S.M., Metcalfe, C., Refsum, H., et al. (2010) Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: A Case-Control Study, Systematic Review, and Me-ta-Analysis. Cancer Epidemiology, Biomarkers & Prevention, 19, 1632-1642. http://dx.doi.org/10.1158/1055-9965.EPI-10-0180 [Google Scholar] [CrossRef]
|
|
[6]
|
Qin, X., Li, J., Cui, Y., et al. (2012) MTHFR C677T and MTR A2756 Gpolymorphisms and the Homocysteine Lowering Efficacy of Different Doses of Folic Acid in Hypertensives Chinese Adults. Nu-trition Journal, 11, 1-7.
http://dx.doi.org/10.1186/1475-2891-11-2 [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
王新, 董丹. 小剂量叶酸联合维生素治疗高同型半胱氨酸血症的临床疗效[J]. 实用心脑肺血管病杂志, 2014, 22(11): 112-113.
|
|
[8]
|
Gopinath, B., Flood, V.M., Rochtchina, E., et al. (2013) Homocysteine, Folate, Vitamin B-12, and 10-y Incidence of Age-Related Macular Degeneration. The American Journal of Clinical Nutrition, 98, 129-135.
http://dx.doi.org/10.3945/ajcn.112.057091 [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
喻莉, 万安琪, 胡明. 同型半胱氨酸与脑梗死的相关性研究[J]. 现代预防医学, 2012, 39(24): 6466-6467.
|
|
[10]
|
张平, 朱斌, 闫海清, 等. 中青年进展性脑卒中患者病因分型及危险因素分析[J]. 脑与神经疾病杂志, 2014, 22(3): 184-187.
|
|
[11]
|
Zhang, W., Sun, K., Chen, J., et al. (2009) High Plasma Homocysteine Levels Contribute to the Risk of Stroke Recurrence and All-Cause Mortality in a Large Prospective Stroke Population. Clinical Science, 118, 187-194.
http://dx.doi.org/10.1042/CS20090142 [Google Scholar] [CrossRef]
|
|
[12]
|
Cui, H.C., Wang, F., Fan, L., et al. (2011) Association Factors of Target Organ Damage: Analysis of 17682 Elderly Hypertensive Patients in China. Chinese Medical Journal, 124, 3676-3681.
|
|
[13]
|
Julve, J., Errico, T.L., Chen, X., et al. (2013) Alterations in the Protein Content and Dysfunction of High-Density Lipoproteins from Hyperho-mo-Cysteinemic Mice. Clínica e Investigación en Arteriosclerosis, 25, 164-173.
http://dx.doi.org/10.1016/j.arteri.2013.07.001 [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Sen, U., Mishra, P.K., Tyagi, N., et al. (2010) Homocysteine to Hydro-gensulfide or Hypertension. Cell Biochemistry and Biophysics, 57, 49-58. http://dx.doi.org/10.1007/s12013-010-9079-y [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
He, K., Merchant, A., Rimm, E.B., et al. (2004) Folate, Vitamin B6, and B12 Intakes in Relation to Risk of Stroke among Men. Stroke, 35, 169-174. http://dx.doi.org/10.1161/01.STR.0000106762.55994.86 [Google Scholar] [CrossRef]
|